New research shows that colorectal cancers are increasing in people under 65. Experts aren’t exactly sure what’s causing the rise in incidence, but they think lifestyle factors such as sedentary ...

As grids grow more strained and costly to expand, utility bills climb, shifting more of the AI boom’s burden onto everyday Americans. In fact, in neighborhoods near new data centers, electricity ...

Add Yahoo as a preferred source to see more of our stories on Google. New Jersey’s four major utilities have until March 5 to explain to regulators why rooftop solar, community solar and battery ...

The New Jersey Board of Public Utilities gave utilities until March 5 to explain interconnection delays. CoreWeave and NVIDIA plan major data center expansion, including a $1.8B Kenilworth project.

Friday's inflation report was a positive for U.S. stocks, but the data didn't move the needle enough to justify another Federal Reserve interest-rate cut in the months ahead. That might explain the ...

A new POLITICO poll shows that views about the artificial intelligence hubs swing if projects are associated with President Donald Trump. The massive server-filled data centers behind each ChatGPT ...

Anna Schecter is the senior coordinating producer for CBS News and Stations' Crime and Public Safety Unit, based in New York. Investigators with the FBI and Pima County Sheriff's Department said they ...

The vast majority of our planet’s oceans remain unexplored, hiding secrets that challenge everything we thought we knew about human history and geology. Every so often, sonar technology or daring deep ...

OpenAI continues its push into healthcare with the launch of ChatGPT Health, a new feature that connects its artificial intelligence chatbot with users' medical records and wellness apps for more ...

We preselected all newsletters you had before unsubscribing.

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...